Testing blood-vessel function and muscle strength in osteoporosis
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at how well your blood vessels work and how strong your muscles are, in women after menopause with osteoporosis. You may be asked to start standard osteoporosis treatment, and the researchers will study pain and changes related to vascular function and sarcopenia (loss of muscle and strength).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 50 or older
- You have postmenopausal osteoporosis and need to start osteoporosis medication now
- You plan to start an osteoporosis drug by mouth or injection (such as bisphosphonates, denosumab, raloxifene, teriparatide, or romosozumab)
- You can understand the study and sign informed consent
- You are covered by the Social Security system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what changes in the body after starting romosozumab (an osteoporosis treatment) in postmenopausal women at higher risk for fractures. Researchers want to understand the treatment’s “mechanism,” which may help improve future osteoporosis care.
This study looks at how bone loss in the hip might affect nerve signals to muscles. It compares postmenopausal women with weak bones (osteoporosis in the hip) to those with normal bone density.
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
This study uses brain scans (MRI) to look at how the brain might be linked to bone health in women with osteoporosis. It compares women with osteoporosis to healthy women of the same age.
This study looks at how bone strength (osteoporosis) and muscle mass (sarcopenia) are related in women who have passed menopause and are younger than 60. It aims to help understand and compare bone and muscle health in women with and without osteoporosis.
This study tests two injectable medications (romosozumab and abaloparatide) that help strengthen bones in women after menopause. Researchers will also look at blood markers to understand why some women respond better to treatment than others.
Hear when a new Osteoporosis, Postmenopausal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.